As of March 12, 2014, SYNARC Inc. was acquired by BioClinica, Inc. SYNARC Inc. provides medical imaging, consultation, and analysis services for pharmaceutical, biotechnology, and medical device industries worldwide. It offers its services in various modalities and therapeutic areas, such as cardiology, neurology, oncology, orthopedics, osteoporosis, osteoarthritis, rheumatoid arthritis, medical devices, and infectious diseases. SYNARC Inc. was formerly known as Advanced Imaging Research Services, Inc. and changed its name to SYNARC Inc. in October 1998. The company was founded in 1998 and is based in Newark, California with additional offices in London, United Kingdom; Beijing, China; Portl...
7707 Gateway Boulevard
Newark, CA 94560
Founded in 1998
SYNARC Announces Alliance with Stanford CCAL to Expand Cardiovascular Offering
Nov 22 13
Synarc and the Stanford Cardiovascular Core Analysis Lab (CCAL) have signed an alliance agreement to jointly provide imaging services for clinical trials. The agreement extends to cardiovascular drug and device trials with the aim of improving sponsor clinical trial services. Synarc and the Stanford CCAL together will provide a seamless service offering to sponsors for clinical trial imaging services supporting cardiovascular drug and medical device trials. The Stanford CCAL /Synarc alliance will also feature enhanced training opportunities for Stanford CCAL fellowship training in clinical trials management as the participants share personnel, training, and other resources. The partnership will combine two innovative, veteran organizations with strong scientific resources and traditions. This will result in unmatched combined offerings retaining innovation and experience while adding capacity for scalability and global reach. This seamless, comprehensive service offering to sponsors promises to accelerate and improve clinical trials to enhance innovation and patient care outcomes.